Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419673
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-14
Brief Title:
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Sponsor:
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences